FDA Inspection 1073583 — Rubicon Research Canada Limited
The FDA completed an inspection of Rubicon Research Canada Limited on Oct 18, 2018 in Concord. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 18, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Concord (Canada)
Additional details
Bioanalytical BA/BE